ArticlePharmaceuticals (Basel, Switzerland)2025

Comparison of Three Consecutive Monthly Administrations Between Aflibercept 8 mg and Brolucizumab 6 mg in Polypoidal Choroidal Vasculopathy.

Yoshiko Fukuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.